NCT05162794

Brief Summary

The trial seeks to test effect of laparoscopic excision of peritoneal endometriosis on pelvic pain. Data will also be gathered on quality of life and neuropathic pain. Patients will be randomized to one of three groups: 1) laparoscopy with excision of endometrial tissue, 2) laparoscopy without excision of endometrial tissue and 3) waiting list control.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jan 2022Jul 2026

First Submitted

Initial submission to the registry

November 17, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 17, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

January 31, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

November 15, 2024

Status Verified

November 1, 2023

Enrollment Period

3.9 years

First QC Date

November 17, 2021

Last Update Submit

November 13, 2024

Conditions

Keywords

Pelvic painQuality of lifePost-surgical neuropathic painEndometriosis surgery

Outcome Measures

Primary Outcomes (1)

  • Pelvic pain measured using NRS

    Pelvic pain intensity (sensory) and unpleasantness (affective) will be measured on 11-point Numeric Rating Scales (0 = no pain to 10 = worst pain imaginable) weekly.

    Change from pre-randomization to 1, 3 and 6 months post-randomization.

Secondary Outcomes (6)

  • Health-related Quality of Life measured using Endometriosis Health Profile-30

    Change from pre-randomization to 1, 3 and 6 months post-randomization.

  • Neuropathic pain symptoms (patient-reported) measured using painDETECT

    Change from pre-randomization to 1, 3 and 6 months post-randomization.

  • Neuropathic pain symptoms (assessed) measured using quantitative sensory testing

    Change from pre-randomization to 6 months post-randomization.

  • Work ability measured using "Work Ability Index"

    Change from pre-randomization to 1, 3 and 6 months post-randomization.

  • Worst pelvic pain measured using NRS

    Change from pre-randomization to 1, 3 and 6 months post-randomization.

  • +1 more secondary outcomes

Other Outcomes (1)

  • Widespread pain measured using body map

    Change from pre-randomization to 1, 3 and 6 months post-randomization.

Study Arms (3)

Active Surgery

OTHER
Other: Laparoscopy with excisionOther: Medical treatment-as-usual

Diagnostic Surgery

OTHER
Other: Laparoscopy without excisionOther: Medical treatment-as-usual

No-surgery control

OTHER
Other: Medical treatment-as-usual

Interventions

Diagnostic laparoscopy will be performed to visually confirm endometriosis in the peritoneum. Then, the relevant tissue will be excised and a histology will be performed.

Active Surgery

Diagnostic laparoscopy will be performed to visually confirm endometriosis in the peritoneum. However, no tissue will be excised and histology will not be performed.

Diagnostic Surgery

Patients continue their hormonal and analgesic treatment-as-usual.

Active SurgeryDiagnostic SurgeryNo-surgery control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult (≥ 18 years) with suspected peritoneal endometriosis undergoing elective surgery for pain relief
  • Pain intensity ≥ 5 on Numeric Rating Scale (NRS) in the four weeks prior to giving consent

You may not qualify if:

  • Other known conditions/diseases that may cause pelvic pain
  • Diagnosed personality disorder, schizophrenia or treatment with anti-psychotics
  • Planned pregnancy during study period
  • Women who cannot read or speak Danish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Regional Hospital Horsens, Department of Obstetrics and Gynecology

Horsens, Central Jutland, DK-8700, Denmark

RECRUITING

Aarhus University Hospital, Department of Obstetrics and Gynecology

Aarhus N, DK-8200, Denmark

RECRUITING

Regional Hospital Herning, Department of Obstetrics and Gynecology

Herning, DK-7400, Denmark

RECRUITING

Regional Hospital Randers, Department of Obstetrics and Gynecology

Randers, DK-8930, Denmark

RECRUITING

Regional Hospital Viborg, Department of Obstetrics and Gynecology

Viborg, DK-8800, Denmark

RECRUITING

Related Publications (1)

  • Marschall H, Forman A, Lunde SJ, Kesmodel US, Hansen KE, Vase L. Is laparoscopic excision for superficial peritoneal endometriosis helpful or harmful? Protocol for a double-blinded, randomised, placebo-controlled, three-armed surgical trial. BMJ Open. 2022 Nov 3;12(11):e062808. doi: 10.1136/bmjopen-2022-062808.

MeSH Terms

Conditions

EndometriosisPelvic Pain

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Axel Forman, PhD, MD

    Aarhus University, Aarhus University Hospital, Denmark

    STUDY DIRECTOR
  • Henrik Marschall, MSc

    University of Aarhus

    PRINCIPAL INVESTIGATOR
  • Dorthe K Thomsen, PhD

    University of Aarhus

    STUDY CHAIR

Central Study Contacts

Henrik Marschall, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2021

First Posted

December 17, 2021

Study Start

January 31, 2022

Primary Completion

January 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

November 15, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

When participant inclusion has ended, data can be shared in accordance with the ICJME guidelines, if relevant research objectives are provided. Data sharing will require approval from the Central Denmark Region and the Danish Data Protection Agency, and the requesting party shall cover any fees associated with data sharing. Requests for data can be addressed to af@clin.au.dk.

Locations